MAP2K7 and hepatocellular carcinoma: Tang et al. (2013) [25] reported that SFB could inhibit Raf kinase to block the MEK/ERK signaling pathway and reduce the level of cyclin D to limit the proliferation of PLC/PRF/5 and HepG2 HCC cells.